Parasite-resistant variants in African genomes: implications for global genetic medicine

Keyphrases

• Sickle Cell Disease 100%
• Resistant Variants 100%
• Apolipoprotein L1 (APOL1) 100%
• Sleeping Sickness 100%
• Genomic Medicine 100%
• African Genomics 100%
• Kidney Disease 50%
• Adaptation 50%
• African Ancestry 50%
• Malaria 50%
• Epistasis 50%
• Plasmodium Falciparum 50%
• Genomic Selection 50%
• Gene Variants 50%
• Survival Benefit 50%
• Drug Target 50%
• Cell mutation 50%
• Potential Therapy 50%
• Trypanosoma Brucei 50%
• Parasitic Infection 50%
• Nephropathy 50%
• System Therapy 50%
• APOL1 Gene 50%
• Selection for Resistance 50%
• Health Challenges 50%
• Malaria Protection 50%
• High Genetic Diversity 50%
• Organ Systems 50%

Medicine and Dentistry

• Nephropathy 100%
• Parasite (Microbiology) 100%
• African Trypanosomiasis 100%
• Genetics 100%
• Genetic Variability 50%
• Organ Systems 50%
• Sickle-Cell Disease 50%
• Sickle Cell 50%
• Trypanosoma Brucei 50%
• Parasitic Disease 50%
• Genetic Selection 50%
• Malaria Falciparum 50%
• Malaria 50%
• Drug Targeting 50%
• Epistasis 50%

Immunology and Microbiology

• Sickle Cell 100%
• Parasite 100%
• Malaria 100%
• Genetic Variability 50%
• Plasmodium falciparum 50%
• Organ Systems 50%
• Drug Targeting 50%
• Infectious Disease 50%
• Trypanosoma Brucei 50%
• Epistasis 50%
• Genetic Selection 50%
• Infection 50%